Literature DB >> 10644988

Inhibitory interaction of c-Myb and GATA-1 via transcriptional co-activator CBP.

T Takahashi1, N Suwabe, P Dai, M Yamamoto, S Ishii, T Nakano.   

Abstract

Gene targeting experiments have revealed that transcription factors such as c-Myb and GATA-1 play crucial roles during hematopoietic differentiation. c-Myb is necessary in the immature cells of almost every hematopoietic lineage and GATA-1 is essential for the development of the erythroid lineage. In addition, CREB-binding protein (CBP) acts as a transcriptional adapter for various transcription factors, including c-Myb and GATA-1. In this paper, we show that the transcription factors c-Myb and GATA-1 each inhibit the transcriptional activity of the other and that any possible bipartite complexes c-Myb, GATA-1, and CBP could be formed, but the tripartite complex was hardly formed. The exclusive binding of GATA-1 and c-Myb to CBP is probably the molecular basis for the mutual inhibition of their transcriptional activity. Our data suggest that cross-talk between these three factors might be important for hematopoietic differentiation and that CBP functions as a key molecule during the process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644988     DOI: 10.1038/sj.onc.1203228

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 2.  Insight into the tumor suppressor function of CBP through the viral oncoprotein tax.

Authors:  K Van Orden; J K Nyborg
Journal:  Gene Expr       Date:  2000

3.  GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors.

Authors:  Kenji Kitajima; Masaaki Masuhara; Takumi Era; Tariq Enver; Toru Nakano
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

4.  The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB.

Authors:  Timothy R Geiger; Neelam Sharma; Young-Mi Kim; Jennifer K Nyborg
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

5.  Egr-1 transactivates Bim gene expression to promote neuronal apoptosis.

Authors:  Bo Xie; Chong Wang; Zhihao Zheng; Bin Song; Chi Ma; Gerald Thiel; Mingtao Li
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

6.  Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.

Authors:  Koichi Watashi; Makoto Hijikata; Ayako Tagawa; Takahiro Doi; Hiroyuki Marusawa; Kunitada Shimotohno
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 7.  Molecular control of megakaryopoiesis and thrombopoiesis.

Authors:  Itaru Matsumura; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

8.  GATA-2 functions downstream of BMPs and CaM KIV in ectodermal cells during primitive hematopoiesis.

Authors:  Gokhan Dalgin; Devorah C Goldman; Nathan Donley; Riffat Ahmed; Christopher A Eide; Jan L Christian
Journal:  Dev Biol       Date:  2007-08-16       Impact factor: 3.582

9.  Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb.

Authors:  Nikla Emambokus; Alexandros Vegiopoulos; Ben Harman; Eric Jenkinson; Graham Anderson; Jon Frampton
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

10.  p73 plays a role in erythroid differentiation through GATA1 induction.

Authors:  Fernando Marqués-García; Nuria Ferrandiz; Rosalía Fernández-Alonso; Laura González-Cano; Marta Herreros-Villanueva; Manuel Rosa-Garrido; Belén Fernández-García; José P Vaque; Margarita M Marqués; María Eugenia Alonso; José Carlos Segovia; Javier León; María C Marín
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.